Global Fibromyalgia Drugs Market 2015 - Size, Trends, Growth & Forecast to 2019 - PowerPoint PPT Presentation

Loading...

PPT – Global Fibromyalgia Drugs Market 2015 - Size, Trends, Growth & Forecast to 2019 PowerPoint presentation | free to download - id: 793eb2-NGFkM



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Global Fibromyalgia Drugs Market 2015 - Size, Trends, Growth & Forecast to 2019

Description:

Big Market Research “Global Fibromyalgia Drugs Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, fibromyalgia is a syndrome with an unknown cause and chronic pain and muscle tenderness as the major symptoms. Unlike arthritis, it does not cause joint, muscle or other tissue inflammation. – PowerPoint PPT presentation

Number of Views:16

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Fibromyalgia Drugs Market 2015 - Size, Trends, Growth & Forecast to 2019


1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Global Fibromyalgia Drugs Market 2015-2019
Growth, Global Share, Industry Overview,
Analysis, Trends Opportunities and Forecast
2
Description
Report Overview
About Fibromyalgia According to the National
Institute of Arthritis and Musculoskeletal and
Skin Diseases, fibromyalgia is a syndrome with an
unknown cause and chronic pain and muscle
tenderness as the major symptoms. Unlike
arthritis, it does not cause joint, muscle or
other tissue inflammation. However, fibromyalgia
is known to cause impairment of joints, soft
tissues, and causes significant pain and fatigue.
Fibromyalgia affects women more than men. In the
US, the condition affects more than 5 million
people aged 18 years and above, of which 80-90
are women. There is no particular diagnostic test
for detecting fibromyalgia, and physicians
undertake differential diagnosis to check the
presence of the syndrome. Currently in the US,
only three drugs are approved to treat
fibromyalgia. Off-label treatment is a popular
option to treat fibromyalgia using analgesics,
antidepressants, sedatives, neuroleptics, and
muscle relaxants.   The global fibromyalgia drugs
market to grow at a CAGR of 0.79 over the period
2014-2019.   Read more details at
http//www.bigmarketresearch.com/global-fibromyalg
ia-drugs-2015-2019-market
3
Key Benefits
Summery
 Covered in this Report This report covers the
present scenario and the growth prospects of the
global fibromyalgia drugs market for 2015-2019.
To calculate the market size, the report
considers revenue generated from the sales of
various drugs used in the treatment of
fibromyalgia.   Based on the chemical class of
the drugs used to treat fibromyalgia, the market
is segmented as follows   Serotonin
norepinephrine reuptake inhibitors GABA
analogs Others   The Global Fibromyalgia Drugs
Market 2015-2019, has been prepared based on an
in-depth market analysis with inputs from
industry experts.  
4
Key Benefits
Summery
 This report includes a discussion of the market
in the following three regions   Americas
The major countries here are the US, Canada,
Mexico, and Brazil EMEA The major countries
here are the UK, Germany, Italy, France, Spain,
Israel, South Africa, Egypt, Sudan, Kuwait, Saudi
Arabia, Qatar, and the UAE APAC The major
countries here are Japan, China, Australia,
Singapore, South Korea, and India.   APAC is a
major untapped market with many leading vendors
in the global fibromyalgia drugs market   The
report also presents the vendor landscape and a
corresponding detailed analysis of the top
vendors in the market. The vendor landscape
section includes a market share analysis of the
major vendors along with the competitive
performances of their product portfolios. In
addition, the report discusses the major drivers
that influence the growth of the market. It also
outlines the challenges faced by the vendors and
the market at large, as well as the key trends
emerging in the market.  
5
Key Audiences
Key Regions Americas APAC EMEA   Key
Vendors Actavis Eli Lilly Pfizer   Other
Prominent Vendors Daiichi Sankyo Innovative
Med Concepts Meda Meiji Seika Merck Sharp
and Dohme Switch Biotech Theravance
6
Table Of Contents
Company Profile
Key Market Driver Unmet Medical Needs For a
full, detailed list, view our report   Key Market
Challenge Adverse Events For a full, detailed
list, view our report   Key Market Trend
Expected Entry of ""Me-too"" Drugs For a full,
detailed list, view our report  
7
Table Of Contents
Key Audiences
Key Questions Answered in this Report What will
the market size be in 2019 and what will the
growth rate be? What are the key market
trends? What is driving this market? What are
the challenges to market growth? Who are the
key vendors in this market space? What are the
market opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors?   Enquire About Report
http//www.bigmarketresearch.com/report-enquiry/25
0932  
8
Get Full Information At http//www.bigmarketrese
arch.com/global-fibromyalgia-drugs-2015-2019-marke
t
About PowerShow.com